Moreover, studies suggest a potential role for antibiotics, particularly vancomycin, in treating dysbiosis related to obesity by reducing TNF-α levels in mice and increasing insulin sensitivity in humans [28,29]. Here, INS is linked to obesity due to melanocortin 4 receptor deficiency.